ArticleBMC microbiology2025
Antimicrobial and antibiofilm activities of culture filtrates from Lactiplantibacillus plantarum isolated from traditional dairy products in Menoufia, Egypt.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lactic Acid Bacteria-Derived Postbiotics in Dairy Foods: Definitions, Functions and Regulatory Challenges.Microorganisms · 2026Review
- Lactobacillus strains in the prevention and disruption of antimicrobial-resistance in pathogenic microbial biofilms: a review of mechanisms and clinical perspective.Folia microbiologica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe global rise in multidrug-resistant (MDR) bacterial infections poses a serious threat to public health, largely driven by the overuse and misuse of antibiotics. In this context, lactic acid bacteria (LAB) and their postbiotic metabolites have attracted attention for their natural antimicrobial and antibiofilm activities. This study aimed to evaluate the effects of LAB-derived postbiotics against four clinically relevant pathogens: Escherichia coli ATCC 25,922, Staphylococcus aureus ATCC 6538, Pseudomonas aeruginosa ATCC 9027, and a clinical isolate of Klebsiella pneumoniae.
resultsLAB strains were isolated from traditional fermented dairy products in Menoufia, Egypt, including Kareish cheese, Rayeb milk, and local yoghurt, using MRS agar medium. Among twelve active isolates, strain EH1 demonstrated the highest inhibitory activity. Identification via VITEK 2 and 16 S rRNA sequencing confirmed the isolate as Lactiplantibacillus plantarum. Optimal culture conditions for EH1 included 48 h incubation at 37 °C, pH 7.0, with yeast extract and sucrose as the preferred nitrogen and carbon sources, respectively. Antibiofilm activity was confirmed through Congo red agar assay, agar well diffusion, ELISA-based quantification, and visualization by SEM and TEM, all indicating substantial disruption of biofilm structure and cell morphology.
conclusionsPostbiotics produced by L. plantarum exhibited strong antibacterial and antibiofilm activity against resistant bacterial strains. These results highlight the promising potential of LAB-derived metabolites as natural, safe, and effective alternatives for inhibiting biofilm formation and mitigating the growing threat of antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.